Coherus Biosciences Inc (NASDAQ:CHRS) Initiates Patent Infringement Battle With Amgen, Inc. (NASDAQ:AMGN) Over Humira Biosimilar – FDA Headlines

Coherus Biosciences Inc (NASDAQ:CHRS) Initiates Patent Infringement Battle With Amgen, Inc. (NASDAQ:AMGN) Over Humira Biosimilar  FDA Headlines

Feb 15, 2019 | Business. Coherus Biosciences Inc (NASDAQ:CHRS) Initiates Patent Infringement Battle With Amgen, Inc. Coherus Biosciences Inc …